昊帆生物
(301393)
| 流通市值：21.34亿 | | | 总市值：54.75亿 |
| 流通股本：4210.48万 | | | 总股本：1.08亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 614,999,722.33 | 974,047,893.62 | 551,505,762.15 | 361,081,038.91 |
| 交易性金融资产 | 878,622,079.09 | 725,234,474.32 | 1,153,291,848.94 | 1,346,222,074.4 |
| 应收票据及应收账款 | 163,371,396.38 | 131,286,092.69 | 126,789,462.4 | 97,164,584.32 |
| 其中：应收票据 | 20,446,551.64 | 15,907,560.17 | 10,274,643.87 | 3,951,011.35 |
| 应收账款 | 142,924,844.74 | 115,378,532.52 | 116,514,818.53 | 93,213,572.97 |
| 应收款项融资 | 1,256,426.51 | 1,306,932 | 1,140,664.28 | 1,174,605.89 |
| 预付款项 | 8,449,954.15 | 2,940,572.61 | 5,768,886.56 | 2,847,673.92 |
| 其他应收款合计 | 1,577,875.91 | 1,331,585.84 | 12,107,076.4 | 11,780,116.78 |
| 存货 | 156,003,577.61 | 137,768,391.28 | 114,347,242.51 | 116,702,724.85 |
| 其他流动资产 | 11,614,653.82 | 9,789,313.4 | 6,243,237.45 | 7,287,237.86 |
| 流动资产合计 | 1,835,895,685.8 | 1,983,705,255.76 | 1,971,194,180.69 | 1,944,260,056.93 |
| 非流动资产: | | | | |
| 固定资产 | 422,196,889.91 | 284,958,329.05 | 289,324,859.85 | 295,057,509.98 |
| 在建工程 | 94,880,250.75 | 68,968,461.45 | 29,544,102.31 | 21,646,451.54 |
| 使用权资产 | 2,591,924.84 | 3,040,297.16 | 3,241,986.32 | 3,689,207.78 |
| 无形资产 | 95,149,229.42 | 65,654,866.93 | 66,014,541.94 | 66,331,056.58 |
| 商誉 | 71,721,165.16 | - | - | - |
| 长期待摊费用 | 505,465.99 | 67,187.84 | 76,020.84 | 100,278.12 |
| 递延所得税资产 | 11,724,218.64 | 4,790,799.89 | 4,949,883.37 | 4,394,454.15 |
| 其他非流动资产 | 15,125,224.34 | 8,745,226.34 | 22,202,147.59 | 14,140,160.54 |
| 非流动资产合计 | 713,894,369.05 | 436,225,168.66 | 415,353,542.22 | 405,359,118.69 |
| 资产总计 | 2,549,790,054.85 | 2,419,930,424.42 | 2,386,547,722.91 | 2,349,619,175.62 |
| 流动负债: | | | | |
| 短期借款 | 10,211,250 | - | - | 0 |
| 应付票据及应付账款 | 84,376,165.47 | 53,488,224.67 | 39,829,890.74 | 41,960,366.84 |
| 其中：应付票据 | 26,374,160 | 19,768,470 | 11,406,610 | 9,999,585 |
| 应付账款 | 58,002,005.47 | 33,719,754.67 | 28,423,280.74 | 31,960,781.84 |
| 合同负债 | 785,944.49 | 516,690.88 | 1,355,472.28 | 1,383,215.73 |
| 应付职工薪酬 | 17,330,610.59 | 10,382,112.95 | 7,017,253.95 | 13,988,900.62 |
| 应交税费 | 10,200,954.55 | 7,401,482.03 | 5,537,842.82 | 6,166,111.31 |
| 其他应付款合计 | 41,603,250.81 | 920,749.65 | 3,522,588.57 | 2,022,789.37 |
| 一年内到期的非流动负债 | 1,378,632.58 | 1,960,062.25 | 1,545,250.64 | 1,679,724.75 |
| 其他流动负债 | 16,000,031.6 | 15,422,962.85 | 10,057,228.89 | 3,961,730.21 |
| 流动负债合计 | 181,886,840.09 | 90,092,285.28 | 68,865,527.89 | 71,162,838.83 |
| 非流动负债: | | | | |
| 租赁负债 | 760,108.57 | 881,335.8 | 1,287,697 | 1,601,611.53 |
| 递延收益 | 9,565,311.94 | 9,449,641.69 | 9,768,754.18 | 7,647,866.67 |
| 递延所得税负债 | 8,151,613.37 | 660,591.4 | 1,142,052.85 | 938,242.75 |
| 非流动负债合计 | 18,477,033.88 | 10,991,568.89 | 12,198,504.03 | 10,187,720.95 |
| 负债合计 | 200,363,873.97 | 101,083,854.17 | 81,064,031.92 | 81,350,559.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,000,000 | 108,000,000 | 108,000,000 | 108,000,000 |
| 资本公积 | 1,688,008,841.09 | 1,689,819,423.48 | 1,688,056,993.19 | 1,686,279,278.15 |
| 减:库存股 | 33,421,938.39 | 42,000,590.49 | 42,000,590.49 | 42,000,590.49 |
| 其他综合收益 | 132,740.77 | 142,913.01 | 25,030.11 | 0 |
| 专项储备 | 4,262,119.58 | 3,793,952.35 | 5,049,670.05 | 4,436,317.49 |
| 盈余公积 | 54,867,446.69 | 53,432,250.22 | 51,579,125.31 | 49,865,214.63 |
| 未分配利润 | 527,576,971.14 | 505,658,621.68 | 494,773,462.82 | 461,688,396.06 |
| 归属于母公司股东权益合计 | 2,349,426,180.88 | 2,318,846,570.25 | 2,305,483,690.99 | 2,268,268,615.84 |
| 股东权益合计 | 2,349,426,180.88 | 2,318,846,570.25 | 2,305,483,690.99 | 2,268,268,615.84 |
| 负债和股东权益合计 | 2,549,790,054.85 | 2,419,930,424.42 | 2,386,547,722.91 | 2,349,619,175.62 |
| 公告日期 | 2025-10-29 | 2025-08-29 | 2025-04-28 | 2025-04-11 |
| 审计意见(境内) | | | | 标准无保留意见 |